Pacira Pharmaceuticals Inc (PCRX)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	638,707	621,403	618,553	613,360	627,091	646,604	609,214	577,203	541,534	491,997	489,092	436,030	429,647	421,097	408,298	435,397	421,026	393,717	372,480	353,983
Total assets	US$ in thousands	1,574,390	1,534,460	1,542,380	1,523,420	1,681,200	1,734,360	1,733,990	1,891,480	2,075,350	1,356,000	1,325,830	1,287,550	1,274,510	1,220,270	866,111	821,379	831,065	807,489	787,843	719,156
Total asset turnover		0.41	0.40	0.40	0.40	0.37	0.37	0.35	0.31	0.26	0.36	0.37	0.34	0.34	0.35	0.47	0.53	0.51	0.49	0.47	0.49

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $638,707K ÷ $1,574,390K
= 0.41

Total asset turnover is a financial ratio that measures how efficiently a company is utilizing its assets to generate revenue. Pacira BioSciences Inc's total asset turnover has shown consistency in the range of 0.40 to 0.44 over the past eight quarters. This indicates that, on average, the company generates $0.40 to $0.44 of revenue for every dollar of assets it holds.

The stability in the total asset turnover ratio suggests that Pacira BioSciences Inc has been able to maintain a relatively consistent level of revenue generation in relation to its asset base. A total asset turnover ratio around 0.40 to 0.44 typically indicates that the company is effectively using its assets to generate sales.

However, it is essential to consider industry benchmarks and trends over time to gain a better understanding of Pacira BioSciences Inc's performance in utilizing its assets to drive revenue. Further analysis and comparison with industry peers can provide insights into the company's operational efficiency and competitiveness.